CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Promopharm SA Company Snapshot
Promopharm SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Promopharm SA with three other pharmaceutical manufacturers in Africa: Glaxo Smithkline Consumer Nig PLC of Nigeria (2016 sales of 14.38 billion Naira [US$47.18 million] ), Societe Adwya SA of Tunisia (84.65 million Dinar [US$34.09 million] ), and Unimed SA which is also based in Tunisia (64.86 million Dinar [US$26.12 million] ).

Sales Analysis. Promopharm SA reported sales of 529.79 million Moroccan Dirhams (US$54.27 million) for the year ending December of 2016. This represents a decrease of 0.6% versus 2015, when the company's sales were 532.84 million Moroccan Dirhams.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Promopharm SA
  Stock Performance Chart for Promopharm SA
 
  Stock Data: Recent Stock Performance:
  Current Price (6/22/2017): 1,300.00
(Figures in Moroccan Dirhams)
1 Week n/a   13 Weeks -4.3%  
4 Weeks -0.4%   52 Weeks -5.0%  
 
Promopharm SA Key Data:
  Ticker: PRO Country: Morocco
  Exchanges: CAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 529,788,922
(Year Ending Jan 2017).
Employees: N/A
  Currency: Moroccan Dirhams Market Cap: 1,300,000,000
  Fiscal Yr Ends: December Shares Outstanding: 1,000,000
  Share Type: Closely Held Shares: 941,166
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.